AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. With its headquarters in the UK, the company employs over 190 staff globally and has support offices worldwide.
Assess feed quality to make smarter nutritional and commercial decisions.
Measure enzyme activity to ensure consistent quality control.
Optimise the feed manufacturing process.
Click on the logos to find out more about our events.
AB Vista is committed to facilitating discussions around animal nutrition technology and gathering experts to provide independent opinions.
Our ultimate aim is to research and apply science that brings real value commercially to the animal production industry.
Stay ahead with the latest news, ideas and events.
AB Vista is committed to bringing new ways of thinking to the global feed industry. Our work attracts enquiring minds who see things differently and embrace the changing landscape – offering our clients an interested, innovative and up-to-date partner.
Thursday, November 2, 2017
Feed additive enzymes play a key role in shaping the future of pork production efficiency, according to AB Vista’s contributing authors of a newly published book.
READ MORE ▶
Speaking at last year's International Phytate Summit, Dr Pete Wilcock discusses how high doses of phytase can improve iron status and productivity.
Tuesday, June 13, 2017
The 6th annual Iowa Swine Day brings together leading figures from the US pork industry to discuss key issues facing the sector.
Monday, June 5, 2017
Our new video gives an insight into the key factors to consider when evaluating phosphorus equivalency, in order to determine the efficacy of a phytase.
Tuesday, May 9, 2017
Read our new white paper highlighting key areas of research which bring new understanding, precision and efficiency to the feed and nutrition sector.
A regular summary of our key stories sent straight to your inbox.
Receive a regular summary of our key stories sent straight to your inbox.
© AB Vista. All rights reserved 2019
A regular summary of our key stories sent straight to your inbox